A multicenter, double-blind, placebo-controlled study was conducted to evaluate the benefit and safety of long-term intravenous iron administration in patients with heart failure. For this purpose, 152 heart failure patients with iron deficiency received a daily intravenous iron supplement for one year. The treatment led to long-term improvements in the patients’ functional capacity (ability to cope with everyday tasks), symptoms, and quality of life. For more information, please read the study.


Ponikowski et al.


Link to article >>